Independent and additive predictive value of total cholesterol content of erythrocyte membranes with regard to coronary artery disease clinical presentation

International Journal of Cardiology

Volumn 150, Issue 1, 2011, Pages 22-27

  Tziakas, Dimitrios N ^a   Chalikias, Georgios K ^a   Stakos, Dimitrios ^a   Tentes, Ioannis K ^a   Papazoglou, Dimitrios ^a   Thomaidi, Adina ^a   Grapsa, Anastasia ^b   Gioka, Georgia ^b   Kaski, Juan Carlos ^c   Boudoulas, Harisios ^d  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^b DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^c ST GEORGE S HOSPITAL   (United Kingdom)

^d BIOMEDICAL RESEARCH FOUNDATION   (Greece)

Author keywords

Cholesterol content; Coronary artery disease; Erythrocyte membranes; Multiple biomarkers

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; APOLIPOPROTEIN B; C REACTIVE PROTEIN; CHOLESTEROL; MYELOPEROXIDASE;

ACUTE CORONARY SYNDROME; ADULT; ANGINA PECTORIS; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ERYTHROCYTE MEMBRANE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL;

ANGINA PECTORIS; BIOLOGICAL MARKERS; CHOLESTEROL; CORONARY ARTERY DISEASE; ERYTHROCYTE MEMBRANE; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES;

EID: 79960040465     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2010.02.022     Document Type: Article

References (31)

1. E. Arbustini Erythrocyte membrane cholesterol. An innocent new marker or an active player in acute coronary syndromes? J Am Coll Cardiol 49 2007 2090 2092
2. G. Pasterkamp, and R. Virmani The erythrocyte: a new player in atheromatous core formation Heart 88 2002 115 116 (Pubitemid 34787753)
3. E. Arbustini, P. Morbini, and A.M. D'Armini Plaque composition in plexogenic and thromboembolic pulmonary hypertension: the critical role of thrombotic material in pultaceous core formation Heart 88 2002 177 182 (Pubitemid 34787776)
4. F.D. Kolodgie, K.G. Herman, and A.P. Burke Intraplaque hemorrhage and progression of coronary atheroma N Engl J Med 349 2003 2316 2325 (Pubitemid 37509739)
5. D. Tziakas, J.C. Kaski, and G.K. Chalikias Total cholesterol content of erythrocyte membranes is increased in patients with acute coronary syndrome J Am Coll Cardiol 49 2007 2081 2089 (Pubitemid 46771054)
6. R.S. Vasan Biomarkers of cardiovascular disease. Molecular basis and practical considerations Circulation 113 2006 2335 2362 (Pubitemid 43947980)
7. R. Schnabel, H.J. Rupprecht, and K.J. Lackner Analysis of N-terminal-pro-brain natriuretic peptide and C-reactive protein for risk stratification in stable and unstable coronary artery disease: results from the AtheroGene study Eur Heart J 26 2005 241 249 (Pubitemid 40222362)
8. R. Arroyo-Espliguero, P. Avanzas, J. Cosín-Sales, G. Aldama, C. Pizzi, and J.C. Kaski C-reactive protein elevation and disease activity in patients with coronary artery disease Eur Heart J 25 2004 401 408 (Pubitemid 38391522)
9. G. Ndrepepa, S. Braun, J. Mehilli, N. von Beckerath, A. Schömig, and A. Kastrati Myeloperoxidase level in patients with stable coronary artery disease and acute coronary syndromes Eur J Clin Invest 38 2008 90 96 (Pubitemid 351143413)
10. S. Koba, T. Hirano, and T. Kondo Significance of small dense low-density lipoproteins and other risk factors in patients with various types of coronary heart disease Am Heart J 144 2002 1026 1035 (Pubitemid 36026916)
11. K. Fox, M.A. Garcia, and D. Ardissino Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology; ESC Committee for Practice Guidelines (CPG). Guidelines on the management of stable angina pectoris: executive summary: the Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology Eur Heart J 27 2006 1341 1381 (Pubitemid 43998110)
12. Kristian Thygesen, Joseph S. Alpert, Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction Universal definition of myocardial infarction Eur Heart J 28 2007 2525 2538 (Pubitemid 47616190)
13. F. Van de Werf, D. Ardissino, and A. Betriu Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology Eur Heart J 24 2003 28 66
14. J.P. Bassand, C.W. Hamm, and D. Ardissino Task Force for Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of European Society of Cardiology. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. The Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society of Cardiology Eur Heart J 28 2007 1598 1660 (Pubitemid 47227122)
15. E. Braunwald Unstable angina: a classification Circulation 80 1989 410 414
16. P.J. Scanlon, D.P. Faxon, and A.M. Audet ACC/AHA guidelines for coronary angiography. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on Coronary Angiography). Developed in collaboration with the Society for Cardiac Angiography and Interventions J Am Coll Cardiol 33 1999 1756 1824
17. J.C. Kaski, M.R. Chester, L. Chen, and D. Katritsis Rapid angiographic progression of coronary artery disease in patients with angina pectoris. The role of complex stenosis morphology Circulation 92 1995 2058 2065
18. D.N. Tziakas, G.K. Chalikias, and I.K. Tentes Interleukin-8 is increased in the membrane of circulating erythrocytes in patients with acute coronary syndrome Eur Heart J 29 2008 2713 2722
19. M.H. Olsen, T.W. Hansen, and M.K. Christensen N-terminal pro-brain natriuretic peptide, but not high sensitivity C-reactive protein, improves cardiovascular risk prediction in the general population Eur Heart J 28 2007 1374 1381 (Pubitemid 47355969)
20. W. Koenig, and N. Khuseyinova Biomarkers of atherosclerotic plaque instability and rupture Arterioscler Thromb Vasc Biol 27 2007 15 26 (Pubitemid 46360377)
21. A.S. Jaffe, L. Babuin, and F.S. Apple Biomarkers in acute cardiac disease. The present and the future J Am Coll Cardiol 48 2006 1 11 (Pubitemid 44202476)
22. R. Carmena, P. Duriez, and J.-C. Fruchart Atherogenic lipoprotein particles in atherosclerosis Circulation 109 2004 III-2 III-7
23. M.S. Pepe, H. Janes, G. Longton, W. Leisenring, and P. Newcomb Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker Am J Epidemiol 159 2004 882 890 (Pubitemid 38657490)
24. M.W. Kattan Evaluating a new marker's predictive contribution Clin Cancer Res 10 2004 822 824 (Pubitemid 38198879)
25. M.W. Kattan Judging new markers by their ability to improve predictive accuracy J Natl Cancer Inst 95 2003 634 635 (Pubitemid 36603708)
26. P. Greenland, and P.G. O'Malley When is a new prediction marker useful? A consideration of lipoprotein-associated phospholipase A2 and C-reactive protein for stroke risk Arch Intern Med 165 2005 2454 2456 (Pubitemid 41720004)
27. D.N. Tziakas, G.K. Chalikias, D. Stakos, and H. Boudoulas The role of red blood cells in the progression and instability of atherosclerotic plaque Int J Cardiol Nov 9 2009 Electronic publication ahead of print. doi:10.1016/j.ijcard. 2009.10.031
28. P.R. Moreno, K.R. Purushothaman, M. Sirol, A.P. Levy, and V. Fuster Neovascularization in human atherosclerosis Circulation 113 2006 2245 2252
29. M.M. Kockx, K.M. Cromheeke, and M.W.M. Knaapen Phagocytosis and macrophage activation associated with hemorrhagic microvessels in human atherosclerosis Atheroscler Thromb Vasc Biol 23 2003 440 446 (Pubitemid 36337220)
30. J.J. Boyle, H.A. Harrington, and E. Piper Coronary intraplaque hemorrhage evokes a novel atheroprotective macrophage phenotype Am J Pathol 174 2009 1097 1108
31. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150